CAML loss causes anaphase failure and chromosome missegregation

per Liu, Yu, Malureanu, Liviu, Jeganathan, Karthik B., Tran, David Dinh, Lindquist, Lonn D., van Deursen, Jan M., Bram, Richard J.
Publicat 2009

A Phase I and Randomized Placebo-Controlled Phase II Trial of Bevacizumab plus Dasatinib in Patients with Recurrent Glioblastoma (GBM): Alliance/NCCTG N0872

per Galanis, Evanthia, Anderson, S. Keith, Twohy, Erin L., Carrero, Xiomara W., Dixon, Jesse G., Tran, David Dinh, Jeyapalan, Suriya A., Anderson, Daniel M., Kaufmann, Timothy J., Feathers, Ryan W., Giannini, Caterina, Buckner, Jan C., Anastasiadis, Panos Z., Schiff, David
Publicat a Cancer (2019)